In a landmark development, Schrödinger, Inc. has entered into a multi-target research collaboration and expanded software licensing agreement with Novartis AG, potentially valued at up to $2.5 billion. This strategic alliance aims to leverage Schrödinger’s advanced computational platform to accelerate drug discovery and development across various therapeutic areas. Under the terms of the agreement, Schrödinger […]
Centene Corporation’s shares experienced their steepest decline in four years, plunging by 7.7% after news of a renewed contract for its subsidiary, Iowa Total Care, to manage Iowa Medicaid services. The four-year contract, beginning July 2025, extends Iowa Total Care’s role in the Iowa Health Link program, covering over 218,600 members. Although securing the contract […]
Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting Acute Bacterial Skin and Skin Structure Infections (ABSSSI), particularly those caused by drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). This launch represents a significant advancement in addressing the growing concern of antibiotic-resistant infections in India. Skin […]
Lupin Limited (Lupin), a global pharmaceutical powerhouse, has been awarded the Establishment Inspection Report (EIR) by the United States Food and Drug Administration (U.S. FDA). The EIR pertains to Lupin’s manufacturing facility located in Dabhasa, Gujarat, following an inspection that took place from April 8 to April 12, 2024. This rigorous inspection concluded without any […]
Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by securing approval from the United States Food & Drug Administration (USFDA) for its Fluoxetine Tablets 10 mg and 20 mg. This development is significant for Strides’ subsidiary, Strides Pharma Global Pte. Limited, Singapore, positioning the company as […]
In a strategic move poised to reshape the landscape of Central Nervous System (CNS) medication accessibility in India, Sanofi India Limited (SIL) and Cipla Limited today unveiled their exclusive partnership. This collaboration focuses on the distribution and promotion of Sanofi India’s CNS product range, including the renowned anti-epileptic medication, Frisium. Under the terms of the […]
Gilead Sciences, Inc. (Nasdaq: GILD) has officially announced the successful acquisition of CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for a staggering $4.3 billion, a move that substantially strengthens Gilead’s position in the liver disease treatment landscape. The acquisition brings CymaBay’s leading investigational product, seladelpar, under Gilead’s expanding liver portfolio, marking a significant step forward in the […]
In a major development within the pharmaceutical industry, Aurobindo Pharma Limited (Aurobindo) announced it has received final approval from the US Food & Drug Administration (USFDA) for the manufacture and market of Mometasone Furoate Monohydrate Nasal Spray, 50 mcg/spray. This approval positions Aurobindo to launch the product in the first quarter of the fiscal year […]
In a significant move for the field of brain health diagnostics, C₂N Diagnostics, LLC, a pioneer in developing advanced diagnostic solutions for Alzheimer’s disease, has secured an investment of up to $15 million from Eisai Inc., a globally recognized human health care company. This strategic partnership underscores a shared commitment between the two firms to […]
Global lifesciences firm, Zydus Lifesciences Limited, recently declared the appointment of Punit Patel as the President and Chief Executive Officer for its Americas wing. He’s set to head the conglomerate’s business in North America, covering a spectrum from generics and injectables to novel therapeutics. This pivotal move emanates from Zydus’s base in Pennington, New Jersey. […]